Portal de Periódicos da CAPES

Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma

2024; Taylor & Francis; Volume: 24; Issue: 6 Linguagem: Inglês

10.1080/14737140.2024.2344647

1744-8328

Paola Tacchetti, Marco Talarico, Simona Barbato, Lucia Pantani, Katia Mancuso, Ilaria Rizzello, Elena Zamagni, Michèle Cavo,

Monoclonal and Polyclonal Antibodies Research

Introduction Modern immunotherapy approaches are revolutionizing the treatment scenario of relapsed/refractory (RR) multiple myeloma (MM) patients, providing an opportunity to reach deep level of responses and extend survival outcomes.